Ten open questions in migraine prophylaxis with monoclonal antibodies blocking the calcitonin-gene related peptide pathway: a narrative review

Ten open questions in migraine prophylaxis with monoclonal antibodies blocking the calcitonin-gene related peptide pathway: a narrative review

Abstract The monoclonal antibodies (mAbs) blocking the calcitonin-gene related peptide (CGRP) pathway, collectively called here “anti-CGRP/rec mAbs”, have dramatically improved preventive migraine treatment. Although their efficacy and tolerability were proven in a number of randomized controlled tr...

Full description

Bibliographic Details
Main Authors: Jean Schoenen, Annelies Van Dycke, Jan Versijpt, Koen Paemeleire
Format: Article
Language:English
Published: BMC 2023-08-01
Series:The Journal of Headache and Pain
Subjects:
CGRP
Monoclonal antibodies
Physiological effects
Clinical practice
Contraindications
Migraine
Online Access:https://doi.org/10.1186/s10194-023-01637-7

Internet

https://doi.org/10.1186/s10194-023-01637-7

Similar Items